comparemela.com

HANOI (Vietnam News/Asia News Network): A private hospital system in Vietnam said on Thursday (March 10) they are set to soon use AstraZeneca's Evusheld, a long-acting antibody combination (tixagevimab co-packaged with cilgavimab), for the prevention of Covid-19 for the most at-risk groups of the population.

Related Keywords

Vietnam ,Republic Of ,Hanoi ,Han I ,Sweden ,United Kingdom ,British ,Swedish ,Astrazeneca Covid ,Astrazeneca Evusheld ,Vietnam Vaccine Company ,World Health Organization ,Ministry Of Health ,Us Federal Drug Agency ,Hanoi Vietnam News Asia Network ,Vietnam Respiratory Association ,Asia News Network ,Anh General Hospital ,Drug Agency ,Anh General ,Professional Director ,Anh Hospital ,Drug ,Covid 19 ,Astrazeneca ,Antibody ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.